JP Morgan Chase’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.03M | Sell |
287,430
-9,254
| -3% | -$117K | ﹤0.01% | 3767 |
|
|
2025
Q4 | $4.92M | Buy |
296,684
+159,736
| +117% | +$2.28M | ﹤0.01% | 3329 |
|
|
2025
Q3 | $1.61M | Sell |
136,948
-1,568
| -1% | -$16.2K | ﹤0.01% | 4244 |
|
|
2025
Q2 | $1.33M | Buy |
138,516
+1,123
| +0.8% | +$6.21K | ﹤0.01% | 4213 |
|
|
2025
Q1 | $861K | Buy |
137,393
+486
| +0.4% | +$2.95K | ﹤0.01% | 4453 |
|
|
2024
Q4 | $1.11M | Buy |
136,907
+1,476
| +1% | +$18.3K | ﹤0.01% | 4557 |
|
|
2024
Q3 | $2.45M | Buy |
135,431
+1,074
| +0.8% | +$15K | ﹤0.01% | 3847 |
|
|
2024
Q2 | $1.38M | Sell |
134,357
-4,095
| -3% | -$42.2K | ﹤0.01% | 4053 |
|
|
2024
Q1 | $1.47M | Sell |
138,452
-7,585
| -5% | -$64.4K | ﹤0.01% | 4074 |
|
|
2023
Q4 | $1.33M | Buy |
146,037
+1,281
| +0.9% | +$11K | ﹤0.01% | 4135 |
|
|
2023
Q3 | $1.5M | Buy |
144,756
+10,760
| +8% | +$148K | ﹤0.01% | 3778 |
|
|
2023
Q2 | $1.92M | Buy |
133,996
+409
| +0.3% | +$4.72K | ﹤0.01% | 3577 |
|
|
2023
Q1 | $954K | Buy |
133,587
+4,438
| +3% | +$39K | ﹤0.01% | 4073 |
|
|
2022
Q4 | $1.45M | Sell |
129,149
-42,221
| -25% | -$435K | ﹤0.01% | 3808 |
|
|
2022
Q3 | $1.9M | Buy |
171,370
+583
| +0.3% | +$5.55K | ﹤0.01% | 3517 |
|
|
2022
Q2 | $1.44M | Sell |
170,787
-4,775
| -3% | -$49.1K | ﹤0.01% | 3822 |
|
|
2022
Q1 | $2.39M | Buy |
175,562
+3,001
| +2% | +$48.5K | ﹤0.01% | 3616 |
|
|
2021
Q4 | $3.39M | Buy |
172,561
+3,573
| +2% | +$84.1K | ﹤0.01% | 3377 |
|
|
2021
Q3 | $5.42M | Buy |
168,988
+156,643
| +1,269% | +$5.21M | ﹤0.01% | 2969 |
|
|
2021
Q2 | $418K | Sell |
12,345
-182,029
| -94% | -$6.52M | ﹤0.01% | 4810 |
|
|
2021
Q1 | $7.3M | Buy |
194,374
+7,368
| +4% | +$308K | ﹤0.01% | 2639 |
|
|
2020
Q4 | $6.21M | Buy |
187,006
+24,411
| +15% | +$989K | ﹤0.01% | 2619 |
|
|
2020
Q3 | $5.82M | Buy |
162,595
+2,476
| +2% | +$85.7K | ﹤0.01% | 2439 |
|
|
2020
Q2 | $5.27M | Buy |
160,119
+156,575
| +4,418% | +$6.02M | ﹤0.01% | 2413 |
|
|
2020
Q1 | $91K | Buy |
3,544
+35
| +1% | +$1.17K | ﹤0.01% | 4549 |
|
|
2019
Q4 | $109K | Buy |
+3,509
| New | +$88.2K | ﹤0.01% | 4869 |
|
Other funds holding PHAT
FLSM
MVM
CG
VCM
NMC
6CM
